InvestorsHub Logo
Followers 41
Posts 3686
Boards Moderated 0
Alias Born 03/28/2013

Re: Couch post# 75959

Friday, 11/01/2013 12:17:55 AM

Friday, November 01, 2013 12:17:55 AM

Post# of 409994
Very odd that people would continue to present misinformation after they note the conference call where they can hear what was actually said or read the transcript. Trials are be initiated and plan to submit results to FDA in 6 months for the twice a day Oxycontin product.

From the transcript from 6 weeks ago. I suspect we will get an announcement here shortly. This is just one of a bunch of items I am expecting from the company this year.

"Well, our next step is to capitalize on that, as for our clinical trials. We are initiating clinical trial within the next two to three months, okay on our twice-a-day. As I said earlier, we have already conducted a study on 19 subjects on the once-a-day and the results were phenomenal. So, we are going for the twice-a-day right now on a full subject.

And we will decide the next step after that. We are hoping as per our communication with the FDA that we will go through three stages or three things over the next six months before we finally are ready to submit our ANDA for approval."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News